Multiple Myeloma Patient Recruitment in Rhode Island

TheraNovex connects clinical trial sponsors with pre-screened, eligible Multiple Myeloma patients across Rhode Island, including Providence, Cranston, Warwick, and beyond.

Multiple myeloma patient recruitment for newly diagnosed, relapsed/refractory, and high-risk cytogenetics studies.

Who qualifies: Adults with multiple myeloma, including newly diagnosed and relapsed/refractory patients with specific cytogenetic profiles.

Recruitment challenges: Complex prior treatment history requirements and renal function eligibility criteria.

Our approach: Hematology center partnerships, myeloma patient registry access, and biomarker pre-screening support.

Our recruitment network spans all major metropolitan areas in Rhode Island, ensuring broad geographic coverage for your Multiple Myeloma trial.